Yongxin Li

Dr. Yongxin Li

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
RZRan Zheng
Ran Zheng
ZWZhen Wang
Zhen Wang
YLYongxin Li
Yongxin Li
YZYuanqing Zhang
Yuanqing Zhang
FNFang Nie
Fang Nie
Background/Objectives : Preoperative differentiation among benign thyroid nodules, follicular variant papillary thyroid carcinoma (FV-PTC), and classical papillary thyroid carcinoma (C-PTC) remains clinically challenging. FV-PTC is particularly difficult to identify due to its substantial sonographic and cytological overlap with both benign nodules and other malignant subtypes, frequently resulting in overtreatment or delayed diagnosis. This study aimed to develop and validate an interpretable multimodal model for accurate three-class discrimination using routine ultrasound images, with a specific focus on improving the preoperative identification of FV-PTC. Methods: This retrospective study included 479 pathologically confirmed thyroid nodules from 462 patients. Conventional ultrasound features and radiomics features extracted from grayscale ultrasound and color Doppler flow imaging were used to construct three predictive models: a Conventional Ultrasound model (conventional ultrasound features only), a Radiomics model (radiomics features only), and an Integrated model (combined features). Each model was trained using four machine learning classifiers. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and F1 score. Model interpretability was assessed using SHapley Additive exPlanations (SHAP) analysis, and clinical usefulness was evaluated using decision curve analysis (DCA). Results: The support vector machine (SVM)-based Integrated Model achieved the best overall performance. In the independent testing cohort, the AUCs were 0.853 for FV-PTC, 0.882 for C-PTC and 0.928 for benign nodules. The Integrated Model showed the greatest improvement for FV-PTC, with a ΔAUC of 0.141 compared with the Conventional Ultrasound Model. SHAP (SHapley Additive exPlanations) analysis identified wavelet-HL_gldm_Dependence and wavelet-HH_glcm_InverseVariance as the two most important radiomics predictors in both the Radiomics Model and the Integrated Model, demonstrating robust cross-model stability and high discriminative power. Conclusions: The SVM-based Integrated Model demonstrated promising performance for three-class classification of thyroid nodules and enhanced the preoperative identification of FV-PTC. This approach may provide an interpretable and noninvasive decision-support tool for refining subtype-specific risk stratification and supporting individualized clinical management.

29 October 2025 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
TRTing Ruan
Ting Ruan
WWWenjun Wu
Wenjun Wu
MPMingji Piao
Mingji Piao
YSYihan Sun
Yihan Sun
XJXingai Ju
Xingai Ju
JCJianchun Cui
Jianchun Cui
Objective: This study aims to evaluate the value of a machine learning model based on tongue features in the adjunctive diagnosis of Hashimoto’s thyroiditis (HT) and its concomitant hypothyroidism. Methods: Tongue images and related clinical data were retrospectively collected from 120 HT patients (60 each from the euthyroid group and the hypothyroidism group), and the tongue region was segmented by preprocessing, and the image feature dimensions were extracted with 1,125 dimensions. Therefore, four methods, namely, random forest (RF), logistic regression (LR), support vector machine (SVM), and decision tree (DT), were utilized for model training, and 80 tongue images of 40 patients from Lixin County People’s Hospital in Anhui Province were utilized for external validation. The model performance evaluation indexes included AUC (Area Under the Curve), Sensitivity, Specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV). Results: t-Distributed Stochastic Neighbor Embedding (t-SNE) visualization based on the test set revealed a distinguishable clustering trend between the two groups. The key classification features included tongue texture uniformity, body morphological features, and color depth. The AUC of the four models was higher than 0.82, confirming that the tongue image features have significant predictive value for HT, and the lower limit of 95% CI for all models was higher than 0.75, indicating that the models had stable differentiation ability. The AUC of SVM (0.894) was the best, significantly higher than the other models (RF: 0.857, LR: 0.876, and DT:0.828), indicating that the SVM possesses the strongest ability to classify patients with and without HT and the highest stability. The SVM exhibited balanced performance, with a sensitivity of 0.804 and specificity of 0.936. Consequently, it represents the optimal model for achieving an equilibrium between recall and precision. In external validation, the efficacy of the four models is notable, and the trend is consistent with the test set. SVM still demonstrates notable performance and possesses the best generalization ability among the four models. Conclusion: The tongue image-based machine learning model can effectively assist in distinguishing euthyroid from hypothyroidism in HT, offering a non-invasive, low-cost, and intelligent tool for auxiliary diagnosis and disease risk monitoring in primary care settings.

18 March 2026 in Advances in Differential Equations and Control Processes
Verified
Journal Article
Open access
HZHaitao Zheng
Haitao Zheng
DWDehui Wen
Dehui Wen
LZLiwei Zhang
Liwei Zhang
HLHaiyong Lu
Haiyong Lu
XLXiaoyu Li
Xiaoyu Li
YLYongxin Li
Yongxin Li
Colorectal cancer liver metastasis (CRLM) remains a major determinant of long-term outcomes. Existing clinical models are typically static and single-modality, limiting early warning and individualized follow-up. We prospectively enrolled 300 treatment-naïve colorectal cancer patients. We collected preoperative three-phase contrast-enhanced ultrasound (CEUS) dynamic sequences, longitudinal serum marker measurements (EZH2/CD10) from preoperation through 12 months, and 35 clinical–pathological variables. The proposed Dynamic Modality Alignment Network (DMA-Net) includes (i) an imaging encoder based on an enhanced 3D-ResNet18 to extract perfusion kinetics, (ii) a molecular encoder using BiLSTM with temporal attention to model serial biomarkers, and (iii) a clinical encoder (MLP) for structured variables. A dynamic alignment module and cross-modal attention fuse modalities, followed by a discrete-time survival head that outputs month-specific conditional hazards and cumulative risks. On the held-out test set, the tri-modal model achieved an area under the curve (AUC) of 0.918 at 12 months with favorable calibration (Brier score 0.123), outperforming a traditional Cox model built from clinical variables (AUC 0.782, Brier score 0.177). Time-dependent evaluation showed stable AUCs from 3 to 12 months (0.904–0.919). Ablation experiments indicated that imaging and molecular branches contributed most to discrimination, whereas clinical variables improved calibration. Multimodal dynamic modeling integrating CEUS perfusion, longitudinal biomarkers, and clinical variables improves early warning and risk stratification for CRLM, and provides a practical framework to support personalized surveillance.

12 October 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
WGWanqing Gong
Wanqing Gong
XLXiaoyi Liu
Xiaoyi Liu
MWMengli Wang
Mengli Wang
XHXiaowen Hu
Xiaowen Hu
GYGuangping Yan
Guangping Yan
TZTingting Zhang
Tingting Zhang
Background: Pelvic lymph node metastasis is a major determinant of staging, recurrence risk, and treatment selection in cervical cancer, yet conventional magnetic resonance imaging criteria based on nodal size and morphology remain insufficient for occult nodal disease. We developed and temporally validated a multi-sequence magnetic resonance imaging radiomics-clinical fusion framework for pretreatment prediction of pelvic lymph node metastasis. Methods: This single-center retrospective-prospective cohort study included 200 women with histologically confirmed cervical cancer who underwent pretreatment pelvic magnetic resonance imaging. A retrospective training cohort ( n = 100) was accrued from January 2018 to December 2022, and a prospective temporal validation cohort ( n = 100) was accrued from January 2023 to December 2024. Reference standards comprised surgical histopathology in 154 patients and composite clinical-imaging adjudication in 46 patients. Primary tumors were manually segmented on axial T2-weighted imaging and registered to T1-weighted imaging, diffusion-weighted imaging/apparent diffusion coefficient maps, and dynamic contrast-enhanced imaging. An Image Biomarker Standardisation Initiative-compliant radiomics pipeline was used, including resampling, intensity discretization, reproducibility filtering, correlation pruning, and nested feature selection. Clinical, radiomics, clinical-radiomics, and deep fusion models were evaluated in the prospective cohort using discrimination, calibration, decision-curve, and reclassification analyses. Results: The deep fusion model achieved the best validation discrimination, with an area under the receiver operating characteristic curve of 0.910 (95% confidence interval, 0.845–0.959) and an area under the precision-recall curve of 0.849. At the training-derived threshold, accuracy was 0.84, sensitivity was 0.79, specificity was 0.86, positive predictive value was 0.75, negative predictive value was 0.89, and Brier score was 0.125. Deep fusion outperformed the clinical model (area under the curve, 0.730; mean delta area under the curve, 0.180; P < 0.001) and improved reclassification relative to the clinical model. Conclusion: Multi-sequence magnetic resonance imaging radiomics-clinical fusion improved pretreatment risk stratification for pelvic lymph node metastasis in cervical cancer. External multicenter validation is warranted before clinical implementation. These preliminary single-center findings should be interpreted cautiously and require multicenter external validation before broad clinical implementation.

7 August 2026 in Journal of Thoracic Imaging
Verified
Journal Article
Open access
YXYan Xu
Yan Xu
HXHui Xu
Hui Xu
NZNan Zhang
Nan Zhang
YLYongxin Li
Yongxin Li
EZErhui Zhang
Erhui Zhang
Zhaoying WenZhaoying Wen
Zhaoying Wen
Purpose: To investigate the clinical outcomes of acute Stanford type B intramural hematoma (TBIMH) without ulcer-like lesions following medical management and to identify predictors of disease progression. Materials and Methods: A retrospective analysis was performed on patients with acute TBIMH without ulcer-like lesions who received medical management. Patients were categorized into progression and nonprogression groups based on 1-year follow-up computed tomography angiography (CTA). Disease progression was defined as aortic rupture, aortic dissection, aortic enlargement (≥5 mm), or hematoma thickening (≥3 mm), while nonprogression was defined as complete/partial resolution or retention of the hematoma. A multivariate analysis identified the predictors of disease progression, and Kaplan-Meier curves were used to compare survival outcomes. Results: A total of 110 patients (mean age 55.9±10.5 y, 25 females) were included, with 21 patients (19.1%) showing disease progression. Multivariate analysis revealed that the maximum aortic diameter (MAD) (OR=7.6, P =0.003) and maximum CT value of the hematoma (CTmax) (OR=1.04, P =0.025) were independently associated with disease progression. The optimal cutoff values for MAD and CTmax were 40.0 mm (AUC: 0.69, sensitivity: 38.1%, specificity: 92.1%) and 71.9 HU (AUC: 0.68, sensitivity: 76.2%, specificity: 66.3%), respectively. When MAD and CTmax were combined, the AUC increased to 0.75 (sensitivity: 81.0%, specificity: 66.3%). Conclusion: A model based on MAD and CTmax effectively stratifies progression risk in TBIMH without ulcer-like lesions, facilitating early intervention in high-risk patients.

9 July 2026 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
YXYan Xia
Yan Xia
YWYarui Wei
Yarui Wei
ZLZhanru Lan
Zhanru Lan
NWNing Wu
Ning Wu
YLYongxin Li
Yongxin Li
XJXueQin Ji
XueQin Ji
Background: Congenital heart disease (CHD) is a clinically important fetal anomaly. Early-pregnancy fetal cardiac microflow imaging (FCMI) can show low-velocity intracardiac flow, but brief shunt-related, regurgitant, and outflow-tract disturbances remain difficult to recognize when image quality, fetal position, and gestational age vary across examinations. Objective: To evaluate uFlowAM for fetus-level detection and visualization of abnormal intracardiac microflow patterns on early-pregnancy FCMI. Methods: This multicenter diagnostic accuracy study analyzed 650 early-pregnancy FCMI examinations from fetuses referred for suspected CHD or CHD risk assessment, including 500 examinations in the internal cohort and 150 in the external cohort. Standard four-chamber, left ventricular outflow tract (LVOT), and right ventricular outflow tract (RVOT) clips were processed by microflow extraction, cardiac-cycle alignment, signal normalization, and 16-frame windowing. uFlowAM used self-supervised training to learn a 256-dimensional representation of control fetal microflow from temporal-order discrimination and masked-frame reconstruction. Model training used no pixel-level or lesion-level labels. Control embeddings were grouped by view and cardiac phase to build a normal microflow template library, and an abnormality index (AbI) was calculated from latent-space Mahalanobis distances. The operating threshold was calibrated in internal validation and then kept fixed for external testing. Clinical utility was assessed in a 9-reader, 240-case multi-reader multi-case (MRMC) study. Results: Using the fixed operating threshold ( τ * = 2.15), uFlowAM achieved an area under the receiver operating characteristic curve (AUC) of 0.94 (95% CI, 0.92–0.96), sensitivity of 0.92, and specificity of 0.88 in the internal cohort. In the external cohort, AUC was 0.92 (95% CI, 0.88–0.95), with sensitivity of 0.90 and specificity of 0.86. Median reader-level AUC increased from 0.85 to 0.92 with uFlowAM assistance, weighted kappa for subtype agreement increased from 0.62 to 0.78, visibility scores increased from 2.8 ± 0.6 to 4.3 ± 0.5, and median reading time decreased from 78 s to 59 s. Mean inference time was 6.8 ± 1.3 s per case. Conclusions: In this CHD-enriched referral/risk-assessment cohort, uFlowAM detected abnormal early-pregnancy fetal cardiac microflow patterns and improved reader consistency and efficiency on selected fetal cardiac microflow views. The framework should be considered an assistive second-reader tool for early fetal CHD assessment. It should not be used as a substitute for a complete fetal echocardiographic examination.